by Richard Daverman, PhD
November 14, 2013 -- Lilly announced it will spend $350 million in China to increase its production of insulin cartridges. The company emphasized that China is home to the world’s largest population of diabetics – which numbers almost 100 million now and is expected to grow as China’s population adopts western lifestyles. The China investment is part of a larger $1 billion building projects that Lilly has announced since the beginning of the year to increase diabetes drug capacity. More details....
Stock Symbol: (NYSE: LLY)
Help employers find you! Check out all the jobs and post your resume.
